• Explore /
  • Poster
  • / Efficacy and safety of sintilimab plus bevacizumab in metastatic nasopharyngeal carcinoma after failure of platinum-based chemotherapy: An open-label phase II study.

Efficacy and safety of sintilimab plus bevacizumab in metastatic nasopharyngeal carcinoma after failure of platinum-based chemotherapy: An open-label phase II study.

Abstract Poster

Authors

null

Nian Lu

Caner Center, Sun Yat-Sen University, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China

Nian Lu , Yao-fei Jiang , Weixiong Xia , Ying Huang , Chuan-miao Xie , Cheng Xu , Yan-Fang Ye , Guo-Ying Liu , Wei-Xin Bei , Liang-Ru Ke , Wang-Zhong Li , Xin Wang , Changqing Xie , Hu Liang , Xiang Yanqun

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Head and Neck Cancer

Track

Head and Neck Cancer

Sub Track

Advanced/Metastatic Disease

Clinical Trial Registration Number

NCT04872582

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 6031)

DOI

10.1200/JCO.2023.41.16_suppl.6031

Abstract #

6031

Poster Bd #

23

Abstract Disclosures

Similar Posters

First Author: Miao Wang

First Author: Jianqing Zhu

First Author: Zhichao Jiang

First Author: Manish R. Patel